Genomic Landscape of Early-Onset and Familial Latin American Parkinson’s Patients
Authors:
- Emily WaldoEWEmily Waldo
- Henry Mauricio Chaparro-SolanoHCHenry Mauricio Chaparro-Solano
- Mariam IsayanMIMariam Isayan
- Thiago Peixoto LealTLThiago Peixoto Leal
- Felipe Duarte-ZambranoFDFelipe Duarte-Zambrano
- Janvi RamchandraJRJanvi Ramchandra
- Maria Rivera PazMPMaria Rivera Paz
- Mary B. MakariousMMMary B. Makarious
- Carlos HernandezCHCarlos Hernandez
- Emilia M GattoEGEmilia M Gatto
Preprint
Abstract
Background: Parkinson’s disease (PD), the most common neurodegenerative movement disorder, is commonly thought of as an aging and sporadic disease; however, 5-14% of individuals experience disease onset before the age of 50 years (early-onset PD; EOPD) and about 20% have a positive family history. In the case of both EOPD and people with a family history of PD, evidence suggests higher rates of a disease-causing genetic contribution. Objectives: Our goal was to perform a variant screening of seven PD-related genes and 21 genes associated with related parkinsonian disorders to identify pathogenic/likely pathogenic variants and variants of uncertain significance within EOPD and family-history-positive individuals within the Latin American Research Consortium on the Genetics of PD (LARGE-PD). Methods: We performed short-read whole-genome sequencing on a subset of 263 individuals with EOPD and/or a familial history of PD who had no known pathogenic PD variant in genotyping data. Results: Of the analyzed individuals, a monogenic burden in primary and secondary PD genes due to pathogenic or likely pathogenic variants for PD was observed in 4.7%, an additional 5.5% had pathogenic or likely pathogenic variants for Gaucher’s disease, and 2.7% had known risk variants in GBA1 . Conclusions: By expanding the reported spectrum of disease-associated variants in a Latin American population, we identified previously unreported or underrepresented variants that would likely be missed by array-based or targeted screening approaches and contribute to the characterization of EOPD and familial PD in Latin America.Keywords
Funding Information
- Michael J. Fox Foundation (MJFF-026283)
- Parkinson's Foundation (PDGENE-1333334)
- Alzheimer's Disease Sequencing Project (5U01AG076482-03)
- VA Puget Sound Health Care System (5I01ABX005978-2)
- Chan Zuckerberg Initiative (CZIF2002-007045)
- American Parkinson Disease Association (1282087)
- Fulbright Colombia
- Ministry of Science, Technology and Innovation of Colombia
This publication has 31 references indexed in Scilit:
- Genetic Testing by Age at Onset in Parkinson DiseaseJAMA Neurology, 2026
- NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsMovement Disorders, 2024
- Family History in Parkinson's Disease: A National Cross‐Sectional StudyMovement Disorders Clinical Practice, 2024
- Frequency of Hereditary and GBA1‐Related Parkinsonism in Latin America: A Systematic Review and Meta‐AnalysisMovement Disorders, 2023
- Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's DiseaseMovement Disorders Clinical Practice, 2022
- Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future DirectionsMovement Disorders, 2022
- GP2: The Global Parkinson's Genetics ProgramMovement Disorders, 2021
- LARGE‐PD: Examining the genetics of Parkinson's disease in Latin AmericaMovement Disorders, 2017
- Parkinson Disease SubtypesJAMA Neurology, 2014
- dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictionsHuman Mutation, 2011